← Open Payments lookup

MATTHEW HAGEMEYER: Open Payments

NPI 1720209380 · OGDEN, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$407 in 28 payments from 9 companies in 2025. Trend: 2023 $369 · 2024 $415 · 2025 $407

Food & beverage: $407
CompanyPaymentsAmount
ABBVIE INC.14$154
PFIZER INC.4$86
GlaxoSmithKline, LLC.2$37
Astellas Pharma US Inc1$34
Gilead Sciences, Inc.2$31
AstraZeneca Pharmaceuticals LP1$17
Lilly USA, LLC1$16
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$16
Organon LLC2$15

Products named: VRAYLAR, NURTEC ODT, UBRELVY, Veozah, QULIPTA, SHINGRIX, BREZTRI, TRELEGY ELLIPTA.

Industry payments across UT — which companies pay providers there.